SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis.  The company has developed a proprietary and innovative bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad based interface.  This novel therapy has the potential to provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payers significantly less than  biologic therapies.

Runway Growth Capital

Action Potential Venture Capital

Euclidean Capital

Boston Scientific

Citta Capital

New Enterprise Associates

Gilmartin Capital LLC

SVE Capital

Richard King Mellon Foundation

Shangbay Capital

CITA Investissement

Midas Capital

Morgenthaler Ventures

Topspin Fund

Revelation Partners

SetPoint Medical

This holiday season, we want to take a moment to extend our gratitude to all the SetPoint employees who worked so hard to make this year special. Your passion and dedication to developing this novel therapy to help RA patients is deeply inspiring! We celebrated this year’s numerous achievements with some great food and holiday cheer.

Wishing each of you and your loved ones a holiday season brimming with joy, peace, and good health.

This #Thanksgiving, we want to extend our profound gratitude to all the incredible people who make the RESET-RA study possible. We deeply appreciate the dedication and hard work of our partners, investigators, and staff. And to our RA study participants, your resilience and strength are truly inspiring. You are appreciated immensely! We look forward to our continued collaboration with you as we evaluate the therapeutic potential of this technology. Wishing our entire community a warm and joyful Thanksgiving!

🧟‍♀️ 🧛‍♂️ #HappyHalloween2023 🧛‍♀️ 🧟‍♂️ 

Each year, we are amazed at the ingenuity and creativity of our team!

#TheSetPointAdvantage

SetPoint Medical is pioneering bioelectronic medicine therapies to treat autoimmune diseases such as rheumatoid arthritis, Crohn's Disease, and multiple sclerosis. The company has developed a proprietary bioelectronic medicine platform consisting of a micro-regulator programmed via a unique prescription pad-based interface, offering a safe and efficacious alternative to drugs.

COM:SETPOINTMEDICAL

SetPoint Medical

Filings Not Available